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Menopause Symptoms’ Predictors:
The Influence of Lifestyle, Health- and
Menopause-Related, and Sociodemographic
Characteristics
FILIPA PIMENTA, ISABEL LEAL, JOÃO MAROCO,
and CATARINA RAMOS
Psychology and Health Research Unit, ISPA–Instituto Universitário, Lisbon, Portugal
This research explores a causal model of menopausal symptoms
in peri- and postmenopausal women. A community sample
of 710 women was assessed regarding menopausal symptoms,
and sociodemographic, health- and menopause-related, and
lifestyle characteristics. Structural equation modelling was used.
Menopausal status predicted skin/facial hair changes (β = .156;
p <.001), vasomotor (β = .122; p <.001) and sexual symptoms
(β = .158; p <.001). Age was significantly associated with cog-
nitive impairment (β = .087; p = .003), aches/pain (β = .072;
p = .006), urinary (β = .115; p = .004) and also sexual symp-
toms (β = .107; p = .021). Several menopausal symptoms are
predicted, not only by menopausal status, but also by age pro-
gression, among other variables; this should be considered in the
context of a well-adapted menopausal transition.
KEYWORDS menopausal symptoms, predictors, structural equa-
tion modelling, health status, lifestyle
INTRODUCTION
The menopausal transition in women is one more change added to the
effects of the aging process; hormonal changes can induce the appearance
of symptoms that will have an impact on the quality of life (Genazzani,
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Gambacciani, & Simoncini, 2007). However, it is still uncertain which
symptoms are directly related to menopausal status: there is an identified
set of symptoms that are reported in this transitional phase, but there is also
a culture-specific influence in the experience of menopause (Hardy & Kuh,
2002; Obermeyer & Sievert, 2007). Moreover, certain occurrences during the
menopausal period may be considered part of the aging process (Sowers,
2000).
There is evidence that health-related characteristics like body mass
index (BMI), smoking, and physical exercise, as well as sociodemographic
and economic factors, may influence the prevalence of menopausal symp-
toms (Campagnoli, Morra, Belforte, Belforte, & Tousijn, 1981; Gold et al.,
2000; Progetto Menopausa Italia Study Group, 2005; Whiteman et al., 2003).
Given that health behaviors may have an impact on the occurrence of
menopausal symptoms (Dennerstein, 1996), interventions combining phar-
macology and lifestyle changes can be the most effective in preventing
the emergence of clinical occurrences (Franco et al., 2009). Adding to
this, the exploration of menopause in nonclinical samples allows clinicians
and researchers to have a better understanding of the specificities of the
menopausal transition and to deconstruct misconceptions due to biased
sampling (Mansfield & Voda, 1997).
Furthermore, since the studies exploring the correlates of menopausal
symptoms are still scarce (Progetto Menopausa Italia Study Group, 2005),
this study has the aim of exploring, in a community sample of peri- and
postmenopausal women, if sociodemographic, health- and menopause-
related, and lifestyle variables can predict the severity of menopausal
symptoms.
METHODS
Procedure
This cross-sectional study on menopause with Portuguese women encom-
passes a community sample, which was mainly recruited through schools
and universities in the city of Lisbon. The inclusion criteria in this research
were gender (female) and age (between 42 and 60 years). The American
Psychological Association’s standards on the ethical treatment of partici-
pants were followed. A written informed consent form was delivered to all
participants, explaining the aims of the study, and emphasizing that the par-
ticipation in this research was voluntary and that participants could interrupt
their collaboration at any time, without any consequences.
After receiving the informed consent form and agreeing to participate
in the research, a sample of 1,003 Portuguese women between the ages of
42 and 60 filled in all the instruments adequately (45 were excluded due to
insufficient information).
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142 F. Pimenta et al.
The present research includes 710 of those women, namely, participants
in peri- and postmenopause.
Participants
The 710 participants in peri- and postmenopause gave answers to a validated
inventory for menopausal symptoms, as well as to a questionnaire to
identify the menopausal status and to explore sociodemographic, health-
and menopause-related, and lifestyle characteristics. Table 1 describes the
participants regarding the assessed variables.
Measures
The instruments included the Menopause Symptoms’ Severity Inventory,
MSSI-38 (Pimenta, Leal, Maroco, & Ramos, 2011), which assesses
menopausal symptoms in 38 items, organized in 12 sets (depressive
mood; anxiety; cognitive impairment; aches and pain; skin and facial hair
changes; numbness; body shape changes; perceived loss of control; mouth,
nails and hair changes; vasomotor, urinary, and sexual symptoms). Both the
frequency and intensity of the symptoms are measured in reference to the
previous month, using a 5-point Likert-type scale, which ranges from “never”
to “daily or almost every day” and from “not intense” to “extreme intensity”
respectively. The severity of each symptom is calculated using the mean
between the values of frequency and intensity for each of the symptoms.
The menopausal status was defined according to the Stages of
Reproductive Aging Workshop’s criteria (Soules et al., 2001). Perimenopausal
participants would report a variable cycle length (a difference of more than
7 days than usual), or had skipped two or more cycles and had an amen-
orrhea interval superior to 60 days. Postmenopausal women had at least a
12-month period of amenorrhea. Besides menopausal status, the search for
medical help to manage these symptoms was explored.
Sociodemographic characteristics (age, marital status, number of chil-
dren [or parity], professional status, educational level, family annual income),
as well as health- and menopause-related (presence of a recent disease or of
a psychological problem, use of hormone therapy or herbal/soy products to
manage menopausal symptoms), and lifestyle characteristics (alcohol, cof-
fee and hot beverages intake; smoking; physical exercise; and body mass
index [BMI]), were assessed. Lifestyle habits (namely, alcohol, coffee and hot
beverages intake; smoking; and physical exercise) were assessed in terms
of presence/absence, amount, and/or frequency. Hence, physical exercise,
when present, was measured in terms of times per week and how many
minutes the participant exercised; a mean between weekly frequency and
duration was used in the multivariate model. Coffee and hot beverages
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TABLE 1 Distribution of the Study’s Participants According to Sociodemographic, Health- and
Menopause-Related and Lifestyle Characteristics
Perimenopause Postmenopause
Characteristics n % n %
n 298 412
Age (M ; SD) 47.6 53.9
(3.787) (4.207)
Education
Primary school 28 9.5 62 15.4
Middle school 68 23.1 98 24.4
High school 91 31.0 109 27.1
University degree or higher 107 36.4 133 33.0
Marital Status
Married or in a relationship 218 73.2 277 67.4
Not married or in a relationship 80 26.8 134 32.6
Parity
0 22 7.5 42 10.4
1 97 33.1 104 25.9
2 136 46.4 186 46.3
3 32 10.9 49 12.2
>3 6 2.0 21 5.1
Professional Status
Active 262 89.7 317 78.7
Inactive 30 10.3 86 21.3
Family Annual Income
≤10,000 C 60 23.9 91 26.1
10,001–20,000 C 66 26.3 85 24.4
20,001–37,500 C 65 25.9 79 22.6
37,501–70,000 C 42 16.7 68 19.5
≥70,001 C 18 7.2 26 7.4
HT, Herbal/Soy Therapy or Nothing
HT 13 4.5 49 13.5
Herbal/soy therapy 16 5.5 48 13.3
Nothing 262 90.0 265 73.2
Recent Disease
Yes 51 18.0 95 23.8
No 233 82.0 304 76.2
Recent Psychological Problem
Yes 43 14.8 76 18.9
No 247 85.2 327 81.1
Smoking Behavior
Current smoker 87 29.7 82 20.5
Current nonsmoker 206 70.3 318 79.5
Alcohol Consumption
Yes 157 53.0 192 47.2
No 139 47.0 215 52.8
Coffee Consumption
Yes 266 89.6 344 84.3
No 31 10.4 64 15.7
Hot Beverages Intake
Daily 260 92.3 333 87.7
Occasionally or never 22 7.8 47 12.3
Physical Activity
Yes 127 43.1 197 48.8
No 168 56.9 207 51.2
Body Mass Index (kg/m2)
≤24.9 157 53.0 205 50.6
>24.9 139 47.0 200 49.4
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intake, when present, was assessed in a four-option scale, ranging from
“occasionally” to “more than five per day.” Alcohol intake, when observed,
was measured both in terms of frequency (daily, every weekend, or rarely)
and quantity (until I feel drunk, moderately or less than a glass per occa-
sion); a mean value of both translates the alcohol consumption variable in
the causal model. Finally, for current smokers, smoking was quantified in a
6-point Likert-type scale that ranged from “less than 10 cigarettes per month”
to “more than 40 cigarettes per day”; this quantification integrated the struc-
tural equation model to assert the influence of smoking on the menopausal
symptoms’ severity.
Statistical Analysis
Missing values were interpolated for variables, where their frequency was
lower than 10% of the sample. This was done using the mean interpolation
method. Multicollinearity between the independent variables was evaluated
with the variance inflation factor (VIF) given by SPSS Statistics (v. 19, IBM
SPSS Inc, Chicago, IL). All variables presented a value below 5, indicating
the absence of collinearity (Weisberg, 1985).
The distributions of the studied variables were explored with SPSS
Statistics (v. 19, IBM SPSS Inc, Chicago, IL).
To test the causal model for menopausal symptoms, a structural equa-
tion model was built relating the dependent variables (the 12 menopausal
symptoms) with the 18 independent variables (age; parity; marital and
professional status; income; education; presence of a recent psychologi-
cal problem or a disease; transition from peri- to postmenopause; use of
hormone therapy or herbal/soy products to manage menopause symptoma-
tology; search for medical help to deal with menopause; alcohol, coffee and
hot beverages intake; smoking; physical exercise; and body mass index),
through AMOS software (v. 18, IBM SPSS Inc, Chicago, IL). The quality of
the fit of the structural model was given by chi-square statistics (χ2/df ),
comparative fit index (CFI), goodness of fit index (GFI) and root mean
square error of approximation (RMSEA), and the reference values currently
practiced in structural equation modelling (Byrne, 2001) were used. A two-
step approach was used to evaluate the causal structural model. First, the
factor’s measurement model was evaluated to demonstrate an acceptable
fit. Thereafter, the structural causal model, encompassing the 12 dependent
and the 18 independent variables, was adjusted, and the significances of the
causal trajectories were evaluated.
RESULTS
There is no multicollinearity between the independent variables. The fit
of the measurement model was very good (X2/df = 2.855; CFI = .915;
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GFI = .885; RMSEA = .051 ].049; .054[; CI 90%; p = .212) as it was the one
of the causal model (X2/df = 2.149; CFI = .908; GFI = .884; RMSEA = .040
].038; .043[ CI 90%; p = 1.000).
Table 2 evidences the significant structural weights (standardized
estimates, standard error, and significance level).
Table 3 presents the results of the squared multiple correlations—that
is, the percentage of the variability accounted for by the sociodemographic,
menopause, health-related, and lifestyle variables in the proposed causal
model for each set of symptoms.
DISCUSSION
Body-shape changes, perceived loss of control, depressive mood, and sexual
and urinary symptoms are the menopausal symptoms for which variability
was explained to a greater extent by the sociodemographic, health- and
menopause-related, and lifestyle characteristics included in this research.
The most frequent predictors of menopausal symptoms were educational
level and the presence of a psychological problem.
The menopausal status predicted significant skin and facial hair changes
and vasomotor and sexual symptoms.
Although facial hair and skin modifications are usually indentified as
hormone therapy’s secondary effects (Munarriz et al., 2002), in this group
of peri- and postmenopausal women, these symptoms were not related to
the use of that therapy but, instead, were associated with the menopausal
status. Hypoestrogenia as a consequence of menopause is known for having
an impact on skin; however, so does the aging process (Raine-Fenning,
Brincat, & Muscat-Baron, 2003). In the present research the changes in skin
were significantly associated with the menopausal status, but not with age,
supporting the fact that estrogen’s decline has a stronger impact on the skin’s
conservation than age progression does.
The menopause status has been identified as a robust predictor of
vasomotor symptoms’ occurrence in prior research (Binfa et al., 2004;
Olofsson & Collins, 2000). Moreover, and because hormone therapy is effi-
cient in the decrease of these symptoms, a biological aetiology has been
suggested for hot flashes and night sweats (Blümel et al., 2004). In this sam-
ple, the menopausal status predicted vasomotor symptoms, supporting a
strong association between endogenous estrogens decrease and vasomotor
symptoms. However, other nonhormonal variables, specifically marital sta-
tus, educational level, and parity, were also significantly associated with
these symptoms.
Sexual response has been associated with the menopause status
(Dennerstein & Lehert, 2004; Genazzani et al., 2007), and some authors
support the idea that only vasomotor symptoms and a decrease in sexual
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TABLE 2 Significant Structural Weights of the Independent Variables (Sociodemographic,
Health- and Menopause-Related, and Lifestyle Characteristics) Regarding the Dependent
Variables (Menopausal Symptoms)
Trajectories β(SE)p
Cognitive impairment ← Age .087(.005)∗∗
Aches and Pain ← Age .072(.004)∗∗
Urinary Symptoms ← Age .115(.006)∗∗
Sexual Symptoms ← Age .107(.008)∗
Depressive Mood ← Marital Status −.060(.040)∗∗
Sexual Symptoms ← Marital Status .165(.070)∗∗∗
Vasomotor Symptoms ← Marital Status .079(.051)∗
Numbness ← Professional Status −.073(.072)∗
Depressive Mood ← Educational Level −.163(.014)∗∗∗
Aches and Pain ← Educational Level −.161(.016)∗∗∗
Vasomotor Symptoms ← Educational Level −.112(.014)∗∗
Perceived Loss of Control ← Educational Level −.189(.011)∗∗∗
Numbness ← Educational Level −.187(.018)∗∗∗
Mouth, Nails, and Hair Changes ← Educational Level −.153(.016)∗∗∗
Anxiety ← Educational Level −.093(.015)∗∗∗
Urinary Symptoms ← Educational Level −.091(.020)∗
Sexual Symptoms ← Educational Level −.149(.020)∗∗∗
Skin and Facial Hair Changes ← Household Annual Income .111(.023)∗∗
Vasomotor Symptoms ← Parity −.116(.024)∗∗∗
Mouth, Nails, and Hair Changes ← Parity .084(.027)∗
Vasomotor Symptoms ← Menopausal Status .122(.048)∗∗∗
Skin and Facial Hair Changes ← Menopausal Status .156(.054)∗∗∗
Sexual Symptoms ← Menopausal Status .158(.081)∗∗∗
Vasomotor Symptoms ← Herbal/Soy Products .143(.082)∗∗∗
Numbness ← Herbal/Soy Products .071(.089)∗
Sexual Symptoms ← Herbal/Soy Products .111(.111)∗∗
Body Shape Changes ← Herbal/Soy Products .100(.095)∗∗
Vasomotor Symptoms ← Recent Disease .071(.057)∗
Mouth, Nails, and Hair Changes ← Recent Disease .141(.066)∗∗∗
Depressive Mood ← Recent Psychological Problem .357(.087)∗∗∗
Cognitive Impairment ← Recent Psychological Problem .346(.092)∗∗∗
Aches and Pain ← Recent Psychological Problem .228(.094)∗∗∗
Vasomotor Symptoms ← Recent Psychological Problem .124(.071)∗∗
Perceived Loss of Control ← Recent Psychological Problem .336(.062)∗∗∗
Numbness ← Recent Psychological Problem .145(.091)∗∗∗
Mouth, Nails, and Hair Changes ← Recent Psychological
Problem
.238(.087)∗∗∗
Anxiety ← Recent Psychological Problem .331(.093)∗∗∗
Skin and Facial Hair Changes ← Recent Psychological Problem .234(.087)∗∗∗
Urinary Symptoms ← Recent Psychological Problem .261(.098)∗∗∗
Sexual Symptoms ← Recent Psychological Problem .243(.104)∗∗∗
Body Shape Changes ← Recent Psychological Problem .203(.092)∗∗∗
Aches and Pain ← BMI .074(.006)∗∗
Numbness ← BMI .103(.007)∗∗
Urinary Symptoms ← BMI .222(.008)∗∗∗
Body Shape Changes ← BMI .337(.007)∗∗∗
Perceived Loss of Control ← Smoking −.091(.011)∗
Numbness ← Coffee Intake .067(.029)∗
Vasomotor Symptoms ← Hot Beverages Intake −.075(.030)∗
∗p ≤ .05; ∗∗p ≤ .01; ∗∗∗p ≤ .001
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TABLE 3 Variability of Menopausal Symptoms Accounted for by the Independent Variables
Menopausal Symptoms
% of the Symptoms’ Variability Accounted for by the
Independent Variables
Depressive Mood 16.6
Cognitive Impairment 12.9
Aches and Pain 10.7
Vasomotor Symptoms 10.1
Perceived Loss of Control 16.5
Numbness 9.8
Mouth, Nails, and Hair Changes 12.6
Anxiety 12.2
Skin and Facial Hair Changes 9.1
Urinary Symptoms 17.2
Sexual Symptoms 19.3
Body Shape Changes 16.8
interest are related to menopausal status (Vanwesenbeeck, Vennix, & van
de Wiel, 2001). As expected, the menopausal status significantly predicted
sexual symptoms in this sample. However, so did age progressing, mari-
tal status, educational level, and the presence of a psychological problem.
These outcomes emphasize that it is not only hormonal variations that have
a significant influence on the severity of vasomotor and of sexual symptoms
in peri- and postmenopause.
Besides sexual symptoms, there were other symptoms significantly pre-
dicted by age, namely, cognitive impairment, aches and pain, and urinary
symptoms.
The occurrence of cognitive difficulties during perimenopause was
described previously; however, the authors suggest that these problems are
transitory since there are no differences when comparing women in pre- and
postmenopause (Greendale et al., 2009). Contrary to this, a decline in cog-
nitive function (namely, working memory and perceptual speed) was not
observed across the different menopausal stages in another study (Meyer
et al., 2003). Moreover, it has also been concluded that women attribute
their memory changes during the menopausal transition to physical health
status, levels of stress, and the aging process rather than to the menstrual
cycle and hormone use (Mitchell & Woods, 2001).
Our causal model supports the two latter studies: cognitive impairment
was not predicted by the menopausal status; instead, age progression and
the presence of a psychological problem were strongly associated with more
severe levels of cognitive difficulties.
Joint pain has been referred to as related to menopause (Olofsson
& Collins, 2000); however, this was not the case in this sample, which
evidences aches and pain (including joint pain) as a consequence of aging.
Age also positively predicted urinary symptoms. Lower urinary tract
symptoms have been associated with marital status, presence of a disease,
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menopausal status, and parity (Manonai et al., 2004). In this sample, besides
age, only the presence of a psychological problem and lower educational
level predicted more severe urinary symptoms.
Surprisingly, hot beverages intake was a negative predictor of
vasomotor symptoms. Given that it was expected that hot beverages would
have a positive relation with vasomotor symptoms (Shaw, 1997), it was
hypothesized that women who drank hot beverages more frequently would
be the ones who had less severe (or absent) vasomotor symptoms; this
would allow the maintenance of a high frequency intake of hot bever-
ages, given that this would not promote a vasomotor exacerbation. Another
concomitant conjecture was the possibility that, prior to the present investi-
gation, women with severe vasomotor symptoms had learned by experience,
or had been informed that a frequent ingestion of hot liquids triggers hot
flashes and for that reason they had decreased hot beverages to a less
frequent intake or had stopped consuming hot beverages altogether.
The use of herbal/soy products to manage menopausal symptoms was
significantly associated with more severe vasomotor and sexual symptoms,
as well as with numbness and body-shape modifications. Therefore, the use
of these natural products was not significant in the attenuation of any of
the menopausal symptoms, and it is related to the exacerbation of the men-
tioned symptoms. This might translate an insufficient clinical supervision
and a mismatching between personal needs of the symptomatic women and
products use. Given that clinical prescription is not mandatory and pharma-
ceutical recommendations are only given if women ask for them directly,
there can be an erroneous use of these products, based on an absence of
adequate counseling. As evidenced in a recent study on the decision-making
process regarding the use of natural products for menopausal symptoms,
women present several difficulties, namely, deciding on the adequate prod-
uct, the adequate dosage, and the use of this kind of therapy specifically
for menopausal symptoms. Unrealistic expectations about the efficacy of the
natural products, inaccurate information about them, and the interference
of menopausal symptoms are strongly related to these difficulties (Légarè,
2007).
The absence of an effect between hormone therapy and menopausal
symptoms might be due to the fact that this is a community sample and, thus,
participants might evidence less severe symptomatology than clinic patients,
making the effect of hormone therapy undetectable when comparing with
counterparts not using it.
CONCLUSIONS
The causal model proposed in this study evidences that there are several
symptoms, recognized as menopausal, that are predicted by the menopausal
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status (like skin and facial hair changes, and vasomotor and sexual symp-
toms), but also by sociodemographic characteristics. Others are strongly
associated with the age progression, leading to the question of whether
these symptoms are the result of actual hormonal changes.
This research also highlights the fact that several sociodemographic,
health-related, and lifestyle characteristics play an important role in
menopausal symptoms’ prediction; this conclusion allows the promotion of
strategies, specifically related to certain lifestyle changes, that might lead to
the reduction of the menopausal symptoms’ severity.
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